LeMaitre Vascular's stock price surged 12.20% during intraday trading on Thursday, marking a significant upward movement for the healthcare company.

The sharp rise appears to be driven by positive analyst actions. Wells Fargo raised its price target for LeMaitre Vascular to $94 from $87, and Lake Street Capital Markets reiterated its Buy rating on the stock with a price target of $110.00. These bullish assessments from financial institutions likely fueled investor optimism and buying activity.

The concurrent analyst coverage highlights growing confidence in the company's prospects, contributing to the strong positive momentum seen in the trading session.